Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case

Figures & data

Table 1 EAP: comparison among the major European Countries

Fig. 1 EAP in Italy: ATC class distribution. A 648 list, B well-established use, C 5% fund

Fig. 2 Marketing authorization (MA) for drugs listed in the 648 list

Fig. 3 Approved vs. 648 list indication

Fig. 4 5% fund: total expenditure (in millions) per ATC class

Fig. 5 5% fund: unitary cost (in 1000 s) per each ATC class